Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$11,944,101
+$342,128 QoQ
Shares Held
76,213
+0.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#154
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NewEdge Advisors, LLC holds $832,318,596 across 17 Drug Manufacturers - General names. NVS ranks #10 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
194,721 | $233,554,228 | |
| 2 | JNJ |
Johnson & Johnson
|
917,872 | $233,111,951 | |
| 3 | ABBV |
AbbVie Inc.
|
439,164 | $110,511,228 | |
| 4 | MRK |
Merck & Co., Inc.
|
455,515 | $58,533,677 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
442,389 | $55,891,426 | |
| 6 | GSK |
GSK plc
|
953,574 | $49,986,349 | |
| 7 | AMGN |
Amgen Inc
|
93,040 | $33,691,644 | |
| 8 | PFE |
Pfizer Inc
|
687,769 | $16,561,477 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,944,101 | 76,213 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $11,601,973 | 75,954 | Shares | Sole | 2026-06-03 | |
| 2025-12-31 | $10,414,699 | 75,540 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $9,315,225 | 72,639 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $8,262,925 | 68,283 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,593,770 | 77,088 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,398,534 | 86,307 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $9,821,097 | 85,386 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,195,014 | 105,157 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $37,698,099 | 389,725 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $39,525,514 | 391,458 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $37,935,617 | 372,429 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $36,703,086 | 363,721 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $33,869,616 | 368,148 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,453,166 | 38,064 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,972,523 | 39,107 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,379,086 | 39,975 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $3,359,157 | 38,281 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,265,080 | 37,328 | Shares | Sole | 2022-02-17 | |
| 2021-09-30 | $1,846,509 | 22,579 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $2,119,049 | 23,225 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $2,027,842 | 23,723 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $2,477,937 | 26,241 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $3,985,985 | 45,837 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $19,867,229 | 227,470 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $16,022,426 | 194,329 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||